The chief executive of Dow Chemical on Tuesday shot down speculation that the company is in talks with private equity for a leveraged buyout.

“We are not in discussions with anyone in LBO,” Andrew Liveris told CNBC’s David Faber. “If we were, we would be the first to tell people for the right reasons, and if those reasons ever came forward, of course it would be for long-term shareholder value.”